Business

Viemed Healthcare Announces Year End 2025 Earnings Conference Call Details

LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of

articleViemed Healthcare, Inc.February 24, 20263/company/viemed-healthcare-inc/news/viemed-healthcare-announces-year-end-2025-earnings-conference-call-details
Viemed Healthcare Announces Year End 2025 Earnings Conference Call Details

About this update from Viemed Healthcare, Inc.

[{"type":"text","content":"LAFAYETTE, LA / ACCESS Newswire / February 24, 2026 / Viemed Healthcare, Inc. (the \"Company\" or \"Viemed\") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its Year End 2025 earnings conference call on Thursday, March 5, 2026, at 11:00 a.m. ET.Interested parties may participate in the call by dialing:877-407-6176 (US Toll-Free)+1 201-689-8451 (International)Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=hp8iUwVSFollowing the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com.ABOUT VIEMED HEALTHCARE, INC.Viemed is a provider of home medical equipment and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. Viemed's model emphasizes efficient, high-quality care delivered in the home through a combination of high-touch clinical support and technology-enabled services, including therapy, education, and counseling provided by our clinical practitioners. For more information, visit our website at www.viemed.com.For further information, please contact:Investor [email protected] FitzgeraldChief Financial OfficerViemed Healthcare, Inc.(337) 504-3802SOURCE: Viemed Healthcare, Inc.View the original press release on ACCESS Newswire\n ","length":2903,"tagName":"div"}]

More updates from Viemed Healthcare, Inc.